"Normally, I spend waxing sessions chattering away about the weather (it's sort of hard to have deep conversations when someone is ripping hair off your face). But that day, we spent the entire session talking about how the global medical establishment decided this week to rename PCOS to polyendocrine metabolic ovarian syndrome, or PMOS."
"Despite the original name, PMOS - which affects roughly 170 million, or one in eight, women worldwide - often doesn't result in ovarian cysts. The updated name more accurately reflects how it's both a hormonal and metabolic condition, not purely a reproductive one."
"The reality is that the condition can impact multiple organs and is associated with other health conditions, like insulin resistance, Type 2 diabetes, obesity, cardiovascular disease, and obstructive sleep apnea."
Renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS) aims to better match how the condition presents in many people. PMOS affects about 170 million women worldwide, and ovarian cysts are often not present despite the original name. The updated terminology emphasizes that the condition is both hormonal and metabolic rather than purely reproductive. PMOS can involve multiple organs and is associated with insulin resistance, Type 2 diabetes, obesity, cardiovascular disease, and obstructive sleep apnea. These links support viewing the condition as a broader health risk profile rather than a single reproductive issue.
Read at The Verge
Unable to calculate read time
Collection
[
|
...
]